Sorafenib-induced defective autophagy promotes cell death by necroptosis.
about
Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapyTetrandrine triggers an alternative autophagy in DU145 cells.Characterization of a novel androgen receptor (AR) coregulator RIPK1 and related chemicals that suppress AR-mediated prostate cancer growth via peptide and chemical screening.Necroptosis: an alternative cell death program defending against cancer.SI113, a SGK1 inhibitor, potentiates the effects of radiotherapy, modulates the response to oxidative stress and induces cytotoxic autophagy in human glioblastoma multiforme cells.Cationic PEGylated liposomes incorporating an antimicrobial peptide tilapia hepcidin 2-3: an adjuvant of epirubicin to overcome multidrug resistance in cervical cancer cells.Simultaneous activation and inhibition of autophagy sensitizes cancer cells to chemotherapy.Differences and Similarities in TRAIL- and Tumor Necrosis Factor-Mediated Necroptotic Signaling in Cancer Cells.Relevance of necroptosis in cancer.The Contribution of Necroptosis in Neurodegenerative Diseases.The Autophagy Machinery Controls Cell Death Switching between Apoptosis and Necroptosis.BH3 mimetic Obatoclax (GX15-070) mediates mitochondrial stress predominantly via MCL-1 inhibition and induces autophagy-dependent necroptosis in human oral cancer cells.Sorafenib inhibits therapeutic induction of necroptosis in acute leukemia cells.Cell death-based approaches in treatment of the urinary tract-associated diseases: a fight for survival in the killing fields.Synergistic antitumor activity of low-dose c-Met tyrosine kinase inhibitor and sorafenib on human non-small cell lung cancer cells.Ophiopogonin D', a Natural Product From Radix Ophiopogonis, Induces in Vitro and in Vivo RIPK1-Dependent and Caspase-Independent Apoptotic Death in Androgen-Independent Human Prostate Cancer Cells.
P2860
Q26739959-4E769689-8DEE-4B12-8B9F-DE080CB223D6Q33685445-AEEE5987-EAC4-4E38-A47F-B64B94372BD6Q36386200-BAB7DA88-A752-477A-B37B-79C6FB217035Q36880241-A9A9D9CC-DEC0-4CA1-A1D8-542C072F9FAAQ37085905-AAB2B12E-21DC-4531-B03C-2B047F10183DQ37426906-1FFB59FF-B5C1-41FC-87EA-3BF1915461BAQ37628979-64F416B8-E76B-40D6-AB4D-CAF57EEE08C9Q38751590-6822A729-7684-4854-BB9D-990B50650304Q39030578-40C3732B-5641-4318-BFA9-A642583A4E34Q39223683-6C0F0484-C2C2-4A50-9CE8-3B219F05F075Q39740446-38D49BE0-67DB-442A-A9B8-FC3393BD6E08Q41694352-64F354F1-0382-46DA-A8CA-09C141E7CBCAQ42366610-83DB09C9-48C5-4934-AEAA-8805948EFA13Q47711163-A62DB23F-B895-46DE-9F9F-E26F1B55A00AQ52649739-2EDD806B-493B-4CFB-AD11-789A5118DF18Q55013888-1D461B75-FC79-4DA5-BFBA-2ACAA6F66677
P2860
Sorafenib-induced defective autophagy promotes cell death by necroptosis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Sorafenib-induced defective autophagy promotes cell death by necroptosis.
@en
type
label
Sorafenib-induced defective autophagy promotes cell death by necroptosis.
@en
prefLabel
Sorafenib-induced defective autophagy promotes cell death by necroptosis.
@en
P2093
P2860
P356
P1433
P1476
Sorafenib-induced defective autophagy promotes cell death by necroptosis.
@en
P2093
Ann-Charlotte Björklund
Boris Zhivotovsky
Dan Grandér
Dimitris Chioureas
George Baltatzis
Lars Egevad
Lena Lennartsson
Patricia Rodriguez
Pedro Fonseca
Sten Nilsson
P2860
P304
37066-37082
P356
10.18632/ONCOTARGET.5797
P407
P577
2015-09-22T00:00:00Z